PYRIDIUM

This brand name is authorized in Brazil, Canada, Ecuador, South Africa

Active ingredients

The drug PYRIDIUM contains one active pharmaceutical ingredient (API):

1 Phenazopyridine UNII 0EWG668W17 - PHENAZOPYRIDINE HYDROCHLORIDE

Phenazopyridine is excreted in the urine where it exerts a topical analgesic effect on the mucosa of the lower urinary tract. This action helps to relieve pain, burning, urgency and frequency. The precise mechanism of action is unknown. Read about Phenazopyridine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PYRIDIUM Tablet	Health Products and Food Branch (CA)	MPI, CA: SPM

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04BX06	Phenazopyridine	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BX Other urologicals
Discover more medicines within G04BX06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 534203701115311, 534203702111318
Country: CA	Health Products and Food Branch	Identifier(s): 00476714
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 5454-MAE-04-09
Country: ZA	Health Products Regulatory Authority	Identifier(s): H/18/1728